Search Within

Brenda Y Hurtado

Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (5)
  2. Solid Tumor Oncology Division (5)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  4. GSK Faculty (4)
  5. Department of Pathology and Laboratory Medicine (3)
  6. Thoracic Oncology (3)

More Groups

People
  1. Martin Fleisher (4)
  2. Yevgeniya Bensman (4)
  3. Charles Rudin (3)
  4. Kaitlin Woo (3)
  5. Maria Pietanza (3)
  6. Mark Kris (3)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2018 (1)
  4. 2017 (2)
  5. 2016 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Cancer Research (1)
  3. Cancers (1)
  4. Journal of Thoracic Oncology (1)
  5. Neuro-Oncology (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. American Association for Cancer Research (1)
  3. Elsevier Inc. (1)
  4. MDPI (1)
  5. Oxford University Press (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cancer associated macrophage-like cells are prognostic for highly aggressive prostate cancer in both the non-metastatic and metastatic settings
    Journal Article

    Gironda, D. J.; Bergan, R. C.; Alpaugh, R. K.; Danila, D. C.; Chuang, T. L.; Hurtado, B. Y.; Ho, T.; Adams, D. L.
    Cancers (2023)

    Fulltext@MSK | Save
  • Cancer associated macrophage like cells predict aggressive disease in local and metastatic prostate cancers
    Meeting Abstract

    Gironda, D. J.; Bergan, R.; Alpaugh, R. K.; Danila, D. C.; Chuang, T. L.; Hurtado, B. Y.; Ho, T.; Tang, C. M.; Adams, D. L.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Randomized, double-blind, phase II study of temozolomide in combination with either veliparib or placebo in patients with relapsed-sensitive or refractory small-cell lung cancer
    Journal Article

    Pietanza, M. C.; Waqar, S. N.; Krug, L. M.; Dowlati, A.; Hann, C. L.; Chiappori, A.; Owonikoko, T. K.; Woo, K. M.; Cardnell, R. J.; Fujimoto, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Improved small cell lung cancer (SCLC) response rates with veliparib and temozolomide: Results from a phase II trial
    Meeting Abstract

    Byers, L. A.; Krug, L.; Waqar, S.; Dowlati, A.; Hann, C.; Chiappori, A.; Owonikoko, T.; Woo, K.; Bensman, Y.; Hurtado, B.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Cerebrospinal fluid circulating tumor cells: A novel tool to diagnose leptomeningeal metastases from epithelial tumors
    Journal Article

    Lin, X.; Fleisher, M.; Rosenblum, M.; Lin, O.; Boire, A.; Briggs, S.; Bensman, Y.; Hurtado, B.; Shagabayeva, L.; DeAngelis, L. M.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • A multi-center, randomized, double-blind phase II study comparing temozolomide (TMZ) plus either veliparib (ABT-888), a PARP inhibitor, or placebo as 2nd or 3rd-line therapy for patients (Pts) with relapsed small cell lung cancers (SCLCs)
    Meeting Abstract

    Pietanza, M. C.; Krug, L. M.; Waqar, S. N.; Dowlati, A.; Hann, C. L.; Chiappori, A.; Owonikoko, T. K.; Woo, K.; Bensman, Y.; Hurtado, B.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save